Emerging Role of Targeted Monoclonal Antibodies in Neuromyelitis Optica Spectrum Disorders. [PDF]
Holian AH, Weinshenker BG.
europepmc +1 more source
The neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with neuromyelitis optica spectrum disorders and multiple sclerosis. [PDF]
Sun Q, Ma X, Zhang L, Tian D.
europepmc +1 more source
Spatiotemporal subtypes of brain and spinal cord atrophy in neuromyelitis optica spectrum disorders and multiple sclerosis. [PDF]
Zhuo Z +18 more
europepmc +1 more source
Predict disabling severe attacks in neuromyelitis optica spectrum disorders: warning symptoms and innovative machine learning models. [PDF]
Zhen W +8 more
europepmc +1 more source
Factors associated with cognitive impairment in patients with neuromyelitis optica spectrum disorders from Mexico. [PDF]
Valdivia-Tangarife ER +11 more
europepmc +1 more source
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin [PDF]
core +1 more source
Cerebellar microstructural and functional connectivity changes in patients with neuromyelitis optica spectrum disorders and their correlation with cognitive function: a female-dominated multimodal MRI study. [PDF]
Zhang Y +7 more
europepmc +1 more source
Neuromyelitis optica spectrum disorders with recurrent syncope due to area postrema syndrome: a case report and literature review. [PDF]
Yin H, Wang Y, Xu Y.
europepmc +1 more source
<i>FCRL3</i> genetic variants drive autoimmune pathogenesis in multiple sclerosis and neuromyelitis optica spectrum disorders. [PDF]
Huang HF +6 more
europepmc +1 more source
Optical coherence tomography angiography biomarkers in multiple sclerosis and neuromyelitis optica spectrum disorders: a systematic review. [PDF]
Mirmosayyeb O +6 more
europepmc +1 more source

